Pharma Journalist -

Kite, a Gilead Company and Teneobio, Inc. announced the companies have entered into a license and collaboration agreement through which Kite will receive exclusive rights to certain…
Read More...

Novartis announced the mutual agreement with Aurobindo Pharma USA Inc. to terminate the agreement to sell the Sandoz US generic oral solids and dermatology businesses to Aurobindo…
Read More...

Fate Therapeutics, Inc. announced a global collaboration and option agreement with Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.…
Read More...

ImmunityBio, Inc., a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it is collaborating with Microsoft to leverage the company’s Azure…
Read More...

Citius Pharmaceuticals, Inc. signed an exclusive six-month option agreement to in-license a stem-cell therapy for acute respiratory distress syndrome (ARDS) from a subsidiary of…
Read More...

Bristol Myers Squibb and bluebird bio, Inc. announced the submission of their Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for idecabtagene…
Read More...

Eli Lilly and Company announced an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop…
Read More...

Agilent Technologies Inc. announced the launch of the newest instrument in its Raman technology portfolio. The new Agilent Vaya Raman raw material identity verification system is a…
Read More...

VBI Vaccines Inc. announced a collaboration with the National Research Council of Canada (NRC), Canada’s largest federal research and development organization, to develop a…
Read More...

Ostrich Pharma USA has announced the successful development of ostrich antibodies to the SARS-CoV-2 virus, the expanding use of those antibodies in Japan, and plans for producing and…
Read More...